Enhanced Stop Light Diet (eSLD)
Dietary SupplementeSDL includes reduced energy portion controlled meals for 6 months, encouraged consumption of lower energy shakes and 35 fruits and vegetables per week.
NCT Number: NCT02561754
The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.
Looking for future studies?
Notify Me13 year–21 year
All sexes
Interventional
Not applicable
University of Kansas Medical Center, Kansas City, Kansas, United States
Rates of obesity and obesity related chronic health conditions are higher in adolescents with Intellectual and Developmental Disabilities (IDD) than those in the general population. Many of the negative health consequences observed in obese adults are already present in obese adolescents with IDD.
This study is a 3 group randomized trial to evaluate the intervention delivery system and type of reduced energy diet. The investigators will randomize 123 overweight/obese adolescents with mild to moderate IDD to one of 3 groups for an 18 month trial (6 month weight loss; 12 month weight maintenance):
group 1) Face-To-Face/CD
group 2) Technology delivery/CD
group 3) Technology delivery/eSLD.
All participants will receive a progressive program of physical activity. Participants on the CD diet will be asked to consume a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet. Participants on the eSLD will consume pre-packaged portion controlled meals with the addition of 5 fruits and vegetables per day.
FTF will meet with a health educator and will track progress using pen and paper records for both physical activity and diet. TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
eSDL includes reduced energy portion controlled meals for 6 months, encouraged consumption of lower energy shakes and 35 fruits and vegetables per week.
CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.
FTF will meet with a health educator in person and will track progress using pen and paper records for both physical activity and diet.
TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.
TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.
Time frame: Change in weight from baseline to 6 months
Participants will be weighed in shorts and a t-shirt , on a calibrated scale to the nearest 0.1 kg.
Time frame: Change in weight from baseline to 18 months
Participants will be weighed in shorts and a t-shirt between 7 and 10 AM, in duplicate, on a calibrated scale to the nearest 0.1 kg.
University of Kansas Medical Center
Other
Acronym: IDDAdol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02714868
Autism, Autism Spectrum Disorder
View Trial DetailsNCT00597948
Abnormalities, Multiple, Autism Spectrum Disorder
Portland, Oregon, United States
View Trial DetailsNCT06997198
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT02792894
Autism Spectrum Disorder, Autistic Disorder
Gujar Khan, Punjab Province, Pakistan
View Trial Details